Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review

L Kazda, K Bell, R Thomas, K McGeechan… - JAMA network …, 2021 - jamanetwork.com
Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

ADHD: Current concepts and treatments in children and adolescents

R Drechsler, S Brem, D Brandeis, E Grünblatt… - …, 2020 - thieme-connect.com
Attention deficit hyperactivity disorder (ADHD) is among the most frequent disorders within
child and adolescent psychiatry, with a prevalence of over 5%. Nosological systems, such as …

Pharmacologic treatment of attention deficit–hyperactivity disorder

S Cortese - New England Journal of Medicine, 2020 - Mass Medical Soc
Pharmacologic Treatment of ADHD Amphetamines and methylphenidate and, less often,
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …

Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study

R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …

The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: a systematic literature review

WS Choi, YS Woo, SM Wang, HK Lim, WM Bahk - PLoS One, 2022 - journals.plos.org
Comorbid psychiatric disorders in adults with ADHD are important because these
comorbidities might complicate the diagnosis of ADHD and also worsen the prognosis …

Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data

E O'Nions, I Petersen, JEJ Buckman… - The Lancet Regional …, 2023 - thelancet.com
Background Autism has long been viewed as a paediatric condition, meaning that many
autistic adults missed out on a diagnosis as children when autism was little known. We …

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic …

KKC Man, A Häge, T Banaschewski, SK Inglis… - The Lancet …, 2023 - thelancet.com
Background Methylphenidate is the most frequently prescribed medication for the treatment
of ADHD in children and adolescents in many countries. Although many randomised …

Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational …

Z Wang, AYL Chan, D Coghill, P Ip… - JAMA internal …, 2021 - jamanetwork.com
Importance The risk of birth and neurodevelopmental complications with prenatal exposure
to antipsychotics is unclear. Objective To evaluate the association between prenatal …

Failure of healthcare provision for attention-deficit/hyperactivity disorder in the United Kingdom: a consensus statement

S Young, P Asherson, T Lloyd, M Absoud, M Arif… - Frontiers in …, 2021 - frontiersin.org
Background: Despite evidence-based national guidelines for ADHD in the United Kingdom
(UK), ADHD is under-identified, under-diagnosed, and under-treated. Many seeking help for …

Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases

L Zhang, L Li, P Andell, M Garcia-Argibay… - JAMA …, 2024 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …